M2 Macrophage Membrane‐Mediated Biomimetic‐Nanoparticle Carrying COX‐siRNA Targeted Delivery for Prevention of Tendon Adhesions by Inhibiting Inflammation

Tendon adhesion is the most common outcome of tendon or tendon‐to‐bone healing after injury. Our group developed a hydrogel‐nanoparticle sustained‐release system previously to inhibit cyclooxygenases (COXs) expression and consequently prevent tendon adhesion and achieved satisfactory results. However, effective treatment of multiple tendon adhesions is always a challenge in research on the prevention of tendon adhesion. In the present study, an M2M@PLGA/COX‐siRNA delivery system is successfully constructed using the cell membranes of M2 macrophages and poly (lactic‐co‐glycolic acid) (PLGA) nanoparticles. Targeting properties and therapeutic effects are observed in mice or rat models of flexor digitorum longus (FDL) tendon injury combined with rotator cuff injury. The results showed that the M2M@PLGA/COX‐siRNA delivery system has low toxicity and remarkable targeting properties to the injured areas. Treatment with the M2M@PLGA/COX‐siRNA delivery system reduced the inflammatory reaction and significantly improved tendon adhesion in both the FDL tendon and rotator cuff tissues. These findings indicate that the M2M@PLGA delivery system can provide an effective biological strategy for preventing multiple tendon adhesions. An M2M@PLGA/COX‐siRNA delivery system is successfully constructed and measured its targeting properties and therapeutic effects on a rat model of flexor digitorum longus tendon injury combined with rotator cuff injury. These findings indicate that the M2M@PLGA delivery system can provide an effective biological strategy for preventing multiple tendon adhesions.